{"id":1311,"date":"2022-02-12T13:58:16","date_gmt":"2022-02-12T21:58:16","guid":{"rendered":"https:\/\/info.pediatricsdirectory.com\/?p=1311"},"modified":"2023-09-09T14:22:33","modified_gmt":"2023-09-09T18:22:33","slug":"1311-2","status":"publish","type":"post","link":"https:\/\/pediatricscommunity.com\/info\/1311\/","title":{"rendered":"Vaccine for neuroblastoma"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-3\">\n<div class=\"wp-block-column is-layout-flow\" style=\"flex-basis:25%\"><i class=\"fas fa-pills clinicaltrial\"><\/i>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow\" style=\"flex-basis:75%\">\n<h4 class=\"wp-block-heading\">OPEN CLINICAL STUDY: a Vaccine in Combination With \u03b2-glucan and GM-CSF in People With Neuroblastoma<\/h4>\n\n\n\n<p>The purpose of the study is to explore the combination of a bivalent vaccine, a sugar called beta-glucan (\u03b2-glucan), and a protein called granulocyte-macrophage colony stimulating factor (GM-CSF) as an effective <a href=\"https:\/\/beta.clinicaltrials.gov\/study\/NCT04936529\">treatment for people with high-risk neuroblastoma<\/a> that is in complete remission. The combination may be effective because the different parts of the treatment work to strengthen the immune system&#8217;s response against cancer cells in different ways.<\/p>\n\n\n\n<p><strong>MORE INFO:<\/strong> <a href=\"https:\/\/beta.clinicaltrials.gov\/study\/NCT04936529\">ClinicalTrials.gov<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n<span class=\"tags-links\"><a href=\"https:\/\/pediatricscommunity.com\/info\/gm-csf\/\" rel=\"tag\">GM-CSF<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/neuroblastoma\/\" rel=\"tag\">neuroblastoma<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/vaccines\/\" rel=\"tag\">vaccines<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/%ce%b2-glucan\/\" rel=\"tag\">\u03b2-glucan<\/a><\/span>","protected":false},"excerpt":{"rendered":"<p>OPEN CLINICAL STUDY: a Vaccine in Combination With \u03b2-glucan and GM-CSF in People With Neuroblastoma The purpose of the study is to explore the combination of a bivalent vaccine, a sugar called beta-glucan (\u03b2-glucan), and a protein called granulocyte-macrophage colony stimulating factor (GM-CSF) as an effective treatment for people with high-risk neuroblastoma that is in [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[9,372],"tags":[1118,1520,2084,2157],"_links":{"self":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1311"}],"collection":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/comments?post=1311"}],"version-history":[{"count":2,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1311\/revisions"}],"predecessor-version":[{"id":5880,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1311\/revisions\/5880"}],"wp:attachment":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/media?parent=1311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/categories?post=1311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/tags?post=1311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}